Life Science Builders

No Patient Left Behind has the support of biomedical innovators who believe patients must be able to afford all appropriate treatments and that all medicines must go generic without undue delay. These Life Science Builders agree that society's payments for branded drugs must be a finite mortgage, oppose the rent extraction that is on the rise in the drug industry today, and stand with No Patient Left Behind in calling on Congress to pass Contractual Genericization.

If you'd like to be listed as a Life Science Builder, please contact us here.

  • Burt Adelman, MD, Atherosclerosis
  • Andy Acker, Investor
  • Gaurav Aggarwal, MD, Investor
  • Rich Aldrich, Investor
  • Catherine Arnold, Advisor
  • Rahul Ballal, PhD, Sickle Cell Anemia
  • Glenn Batchelder, Parkinson's Disease
  • David Beier, Investor
  • Gil Beyen, Cancer
  • Pieter Boelhouwer, Investor
  • Paul Bolno, MD, Neurological Disorders
  • Axel Bolte, Rare Diseases
  • Bruce Booth, DPhil, Investor
  • Janice Bourque, Investor
  • Eamon Brady, Heart Failure
  • Aoife Brennan, MB CHB, Rare Diseases
  • Kevin Buchi, Rare Diseases
  • Brook Byers, Investor
  • Pablo Cagnoni, MD, Cancer
  • Bharatt Chowrira, PhD, Immune Disorders
  • Gustav Christensen, Hereditary Angioedema
  • Ron Cohen, MD, Parkinson's Disease
  • Mark Corrigan, MD, Charcot Marie Tooth
  • Aaron Davis, Investor
  • Bob Deresiewicz, MD, Investor
  • Milind Deshpande, PhD, Infectious Diseases
  • Michelle Dipp, MD PhD, Investor
  • Jon Edwards, PhD, Investor
  • Michael Ehlers, MD PhD, Rare Diseases
  • Riley Ennis, Colorectal Cancer
  • David Epstein, Cancer
  • Doug Fambrough, PhD, Rare Diseases
  • Marsha Fanucci, Rare Diseases
  • Ramin Farzaneh-Far, MD, Complement Disorders
  • Jean-Francois Formela, MD, Investor
  • Cedric Francois, MD PhD, Blindness
  • Patricia Fraser MD, MD, Lupus
  • Howie Furst, MD, Investor
  • Julia Gaebler, PhD, Advisor
  • Ilan Ganot, Duchenne Muscular Dystrophy
  • Scott Gazelle, MD PhD, Investor
  • Michael Gilman, PhD, Cancer
  • David Goeddel, PhD, Investor
  • Corey Goodman, PhD, Investor
  • Robert Gould, PhD, Genetic Disorders
  • Arjun Goyal, MD, Investor
  • Dan Grau, Neurological Disorders
  • Kurt Graves, Type 2 Diabetes
  • Barry Greene, Genetic Disorders
  • Yvonne Greenstreet, MBChB, Genetic Disorders
  • Jim Greenwood, Industry Leader
  • Mike Grey, Rare Diseases
  • David-Alexandre Gros, MD, Autoimmune Disorders
  • Paul Hastings, Cancer
  • Michael Hayden, MD PhD, Neuro/Psychiatric Disorders
  • Martin Heidecker, PhD, Investor
  • Christian Henry, Genetic Diseases
  • Stephen Hoffman, MD PhD, Rare Diseases
  • Rob Hopfner, PhD, Investor
  • Wende Hutton, Investor
  • Troy Ignelzi, Neuropsychiatry
  • Jose Juves, Neurological Disorders
  • Rahul Kakkar, MD, Autoimmune Disorders
  • Matthew Kane, Cancer
  • Alex Karnal, Investor
  • Perry Karsen, Genetic Disorders
  • David Katz, PhD, Cushing's Syndrome
  • Laurie Keating, Rare Diseases
  • Jonathan Kfoury, Advisor
  • Rachel King, Leukemia
  • Nina Kjellson, Investor
  • Rick Klausner, MD, Cancer
  • Peter Kolchinsky, PhD, Investor
  • John Kollins, Migraine
  • Peter Lanciano, Cancer
  • Jonathan Leff, Investor
  • Jeremy Levin, DPhil MB CHB, Neurological Disorders
  • Andrew Levin, MD PhD, Pain
  • Jay Lichter, PhD, Investor
  • Ted Love, MD, Sickle Cell Anemia
  • Jakob Loven, PhD, Investor
  • Steve Lufkin, Infectious Diseases
  • Dan Lyons, PhD, Investor
  • Greg Mann, Cancer
  • John Maraganore, PhD, Genetic Disorders
  • Adam Mikkelson, Investor
  • Marcos Milla, PhD, Autoimmune Disorders
  • Keith Murphy, Organ Damage Repair
  • Janis Naeve, PhD, Investor
  • Michael Narachi, Neurological Disorders
  • Sara Nayeem, MD, Investor
  • Bill Newell, Cancer
  • Jack Nielsen, Investor
  • Tim Noyes, Kidney Disease
  • Gabriel Otte, Colorectal Cancer
  • Michael Panzara, MD, Neurological Disorders
  • Art Pappas, Investor
  • Rob Perez, Investor
  • Matthew Perry, Investor
  • Scott Rakestraw, PhD, Neurological Disorders
  • Adrian Rawcliffe, Cancer
  • Josh Resnick, MD, Investor
  • Ken Rhodes, PhD, Neurological Disorders
  • Wendye Robbins, MD, Fibrotic Diseases
  • Adam Rosenberg, Neurological Disorders
  • Gino Santini, Chronic Pain
  • Vicki Sato, PhD, Infectious Diseases
  • Thilo Schroeder, PhD, Investor
  • Andy Schwab, Investor
  • Pratik Shah, PhD, Neurological Disorders
  • Nimish Shah, Investor
  • Rajeev Shah, Investor
  • Tim Shannon, MD, Investor
  • Laura Shawver, PhD, Cancer
  • Vikram Sheel Kumar, MD, Cancer
  • Steve Sherwin, MD, Cancer
  • David Socks, Investor
  • Jeffrey Solomon, Advisor
  • Tim Springer, PhD, Ulcerative Colitis
  • Steve Squinto, PhD, Investor
  • Otello Stampacchia, PhD, Investor
  • Ken Takanashi, Migraine
  • Ruth Thieroff-Ekerdt, MD, Neurological Disorders
  • Peter Thompson, MD, Cancer
  • Nancy Thornberry, MD, Obesity
  • Jamie Topper, MD, Investor
  • John Tucker, Heart Failure
  • Dave Van Meter, Glaucoma
  • Ypke Van Oosterhout, PhD, Immune Disorders
  • Chandra Vargeese, PhD, Neurological Disorders
  • Mark Velleca, MD PhD, Cancer
  • Gregory Verdine, PhD, Cancer
  • DA Wallach, Investor
  • Graham Walmsley, MD PhD, Investor
  • Frank Watanabe, Psoriasis
  • Greg Weaver, Depression
  • Michael Weiss, Lymphoma
  • Christoph Westphal, MD PhD, Investor
  • Andreas Wicki, PhD, Investor
  • Wendell Wierenga, PhD, Endocrine Disorders
  • Rick Wiessenstein, Advisor
  • Peter Wirth, Cancer
  • Daphne Zohar, Immune Disorders